WADA, world sport’s anti-doping body, will not appeal against the one-month doping sanction levied against tennis world No 2 Iga Swiatek. The Pole recorded a positive test for the banned substance trimetazidine (TMZ) in August.

WADA released its decision after Iga Swiatek sealed a victory against Eva Lys to reach the Australian Open quarterfinals.

The World Anti-Doping Agency will not appeal against the ban given to Poland's Iga Swiatek. The five-time major winner tested positive for heart medication trimetazidine (TMZ) in an out-of-competition sample in August 2024.

World No. 2 and five-time Grand Slam champion Iga Swiatek opened up about her recent one-month doping ban for a positive drug test, describing it as the most challenging period of her tennis career. Speaking on the eve of the Australian Open, Swiatek shared that the ordeal was “pretty chaotic” and labeled it the “worst time” of her life.

The World Anti-Doping Agency (WADA) said on Monday it would not lodge an appeal to the Court of Arbitration for Sport (CAS) in the case of Iga Swiatek after the former world number one tested positive for prohibited substance trimetazidine (TMZ).

Iga Swiatek says she can get "a closure" now that the WADA won't appeal the ITIA's ruling in her doping case but also underlines that she expected this outcome all along. While the world No. 2 was on the court playing against Eva Lys at the Australian Open, the WADA announced that they would not lodge an appeal and take her case to the CAS.

Iga Swiatek felt satisfaction and hoped for closure after the World Anti-Doping Agency (WADA) said on Monday that it would not appeal her case at sport's highest court. WADA's announcement came shortl

Iga Swiatek has spoken for the first time since the World Anti-Doping Agency (WADA) announced it would not appeal to the Court of Arbitration for Sport (CAS) in her doping case. WADA revealed the decision shortly after Swiatek’s 6-0,